Question 1

What software categories do pharmaceutical companies need?

Accepted Answer

Pharmaceutical companies require a distinct technology stack for each stage of their operations. Commercial teams depend on CRM platforms (IQVIA OCE, Veeva Vault CRM) for HCP engagement, sample management, and omnichannel marketing, and on content management platforms (Veeva PromoMats, Vodori Pepper Flow) for MLR review and promotional compliance. Safety and regulatory functions use pharmacovigilance platforms (Oracle Argus, ArisGlobal LifeSphere) for adverse event processing, and regulatory information management systems (RIM) for eCTD submission lifecycle management. Manufacturing operations require ERP systems pre-validated for GMP (Infor CloudSuite Pharma, SAP S/4HANA for Life Sciences), quality management systems (Sparta Systems TrackWise), and serialization platforms (TraceLink) for DSCSA/EU FMD track-and-trace compliance. Market access teams use revenue management platforms (Model N) for government pricing, rebate management, and gross-to-net calculations. AI analytics layers (Saama, IQVIA) increasingly sit across all of these, connecting data from clinical, commercial, and safety systems into unified intelligence.

Question 2

What is pharmacovigilance software and why is it mandatory?

Accepted Answer

Pharmacovigilance (PV) software manages the collection, processing, assessment, and reporting of adverse event information for marketed pharmaceutical products. Regulatory agencies worldwide — FDA, EMA, PMDA, ANVISA, CDSCO, and others — require marketing authorization holders (MAHs) to maintain pharmacovigilance systems capable of receiving spontaneous adverse event reports, processing individual case safety reports (ICSRs) within regulatory timeframes (15 days for serious unexpected events), and submitting periodic safety update reports (PSURs/PBRERs). Failure to maintain an adequate pharmacovigilance system is grounds for regulatory action including product withdrawal. The dominant platforms — Oracle Argus Safety and ArisGlobal LifeSphere — handle case intake (phone, email, literature, social media), medical coding (MedDRA dictionary), narrative generation, causality assessment, regulatory reporting in E2B R3 format, and aggregate reporting. Modern PV platforms integrate NLP and AI to automate case triage, identify duplicate reports, and detect emerging safety signals earlier than traditional statistical methods.

Question 3

What is MLR review and which software manages it?

Accepted Answer

MLR (medical-legal-regulatory) review is the internal approval process pharmaceutical companies use before any promotional content — a sales aid, website, digital ad, patient brochure, or social media post — is used or distributed. Under FDA's Prescription Drug Advertising regulations (21 CFR Part 202), promotional materials must be FDA-compliant: fair-balanced, not misleading, and supported by substantial evidence. The MLR review process routes draft content through medical, legal, and regulatory reviewers for sequential or parallel approval, with each reviewer ensuring the content meets their function's standards. MLR review software (Veeva Vault PromoMats for enterprise pharma, Vodori Pepper Flow for mid-size and specialty pharma) manages the entire promotional content lifecycle: creative briefing, asset creation, reviewer routing with role-based access, comment consolidation, approval stamping, distribution to sales reps or digital channels, expiry management, and withdrawal when a product label changes. A complete audit trail of every review, change, and approval decision is required for FDA inspection readiness.

Question 4

What is pharmaceutical serialization and the DSCSA?

Accepted Answer

Pharmaceutical serialization is the assignment of a unique serial number to every individual drug package (bottle, blister pack, vial) at the point of manufacture, enabling end-to-end track-and-trace of drugs through the supply chain. The Drug Supply Chain Security Act (DSCSA), signed into US law in 2013 and fully implemented in 2023, requires manufacturers, wholesalers, and dispensers to exchange Transaction Information (TI), Transaction History (TH), and Transaction Statements (TS) for every saleable unit change of ownership — creating a full chain of custody that enables detection and rapid removal of counterfeit, stolen, or contaminated drugs from the supply chain. Similar mandates exist in the EU (Falsified Medicines Directive), China, Brazil, Russia, Turkey, and India, each with different data format and reporting requirements. TraceLink is the dominant network-based serialization platform connecting the 330,000+ supply chain partners required to exchange this data, because serialization compliance requires not just software but a network of all trading partners using compatible systems.

Question 5

What is gross-to-net and why does pharma need revenue management software?

Accepted Answer

Gross-to-net (GTN) is the difference between a pharmaceutical product's list price (Wholesale Acquisition Cost/WAC) and the net revenue actually collected after deductions — Medicaid rebates, Medicare Part D coverage gap discounts, 340B ceiling price compliance, commercial managed care rebates, patient assistance programs, chargebacks, and distribution fees. For large pharma companies, gross-to-net deductions can be 40–60% of gross revenue; accurately calculating, accruing, and paying these obligations requires purpose-built software because they depend on complex, time-lagged government pricing calculations (Medicaid Best Price must be recalculated retroactively if list price changes), contract-specific rebate tiers, and quarterly government reporting to CMS. Model N and similar platforms automate these calculations, generate the required government reports (Medicaid State Drug Utilization Data, Part B ASP submissions, FSS pricing tables), manage commercial contract performance and rebate payments, and provide finance teams with real-time visibility into net revenue — data that is essential for accurate financial planning and SEC reporting for publicly traded pharma companies.

Question 6

How is pharma CRM different from regular CRM software?

Accepted Answer

Pharmaceutical CRM is fundamentally different from general CRM platforms like Salesforce because it is built around the unique compliance requirements of pharmaceutical sales and medical engagement. A standard CRM handles contacts and deals; pharma CRM must manage: HCP (healthcare professional) and HCO (healthcare organization) data with identity resolution against NPI registries; sample management with compliance tracking under the Prescription Drug Marketing Act (PDMA), which requires detailed records of every drug sample transferred to a physician; interactions with physicians subject to the Sunshine Act (Open Payments), requiring disclosure of transfers of value; calls and approved email communications governed by FDA promotional compliance; managed markets access, formulary status, and payer restrictions; and medical science liaison (MSL) scientific engagement workflows that are completely separate from commercial promotion. IQVIA's OCE and Veeva Vault CRM have pre-built data models, compliance guardrails, and integrations with sample management, claims data, and consent management that generic CRM platforms require months of custom development to replicate — and without the regulatory validation documentation that pharma IT and compliance teams require.

Question 7

What does pharma software implementation cost?

Accepted Answer

Pharma software costs depend heavily on company size, module scope, and whether an implementation is a net-new deployment or a replacement. Enterprise PV platforms (Oracle Argus) involve implementation projects of $500,000–$3M+ for a validated global deployment, plus $300,000–$800,000 annually in license and support fees for mid-to-large pharma. Veeva Vault PromoMats MLR review typically costs $100,000–$500,000 annually for a specialty pharma commercial team, scaling upward with product volume. IQVIA OCE commercial CRM for a US field force of 200+ reps runs $1–3M annually including data subscriptions. Serialization platforms like TraceLink are typically $200,000–$1M+ annually depending on product count, pack levels, and trading partner volume. Revenue management platforms (Model N) run $500,000–$2M+ annually for a pharma company with significant government business. GMP-validated ERP implementations (Infor CloudSuite Pharma) typically involve $1–5M implementation projects plus $200,000–$800,000 in annual license fees. Total pharma software spend for a commercial-stage specialty pharma company typically ranges from $2–10M annually; top-20 pharma companies spend $100M+ annually across their technology portfolio.

Question 8

How does TechRadiant evaluate and rank pharma software companies?

Accepted Answer

TechRadiant's pharma software rankings use a five-dimension scoring framework designed around the technology needs of commercial, clinical, regulatory, and manufacturing pharma operations. We evaluate each platform across: Sales & CRM (HCP engagement, sample management, field force effectiveness, omnichannel marketing, and Sunshine Act compliance capabilities); Content & MLR (promotional content lifecycle, MLR review workflow, audit trail completeness, distribution management, and regulatory compliance for FDA advertising guidance); Pharmacovigilance (case processing automation, regulatory reporting, signal detection, aggregate report generation, and global health authority submission capability); Supply Chain & Manufacturing (serialization and DSCSA compliance, GMP batch record management, quality management, and ERP integration depth); and Analytics & AI (data integration breadth, machine learning capabilities, predictive analytics, real-world evidence, and business intelligence tooling). Evaluations draw on published product documentation, customer reference interviews at commercial pharma companies, FDA inspection observation analysis, and hands-on platform assessments. No vendor pays for placement or influences scores, and rankings are refreshed quarterly.

Best Pharma Software Companies